CLINICAL_TRIALS trial_result · 2009-09-16

Clinical Trial Update: Study the Safety and Effectiveness of MK7009 in Hepatitis C Infected Patients (MK-7009-004)(COMPLETED) [Phase 1]

The Phase 1 study MK-7009-004 evaluating MK-7009 in hepatitis C patients has completed and results were posted in September 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED | Results posted: 2009-09-16